济川药业: 湖北济川药业股份有限公司2025年半年度报告摘要

| | | | | | | | | | | 持有有限 | | | | | | | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 的 | | 股东性 | | 持股比 | | | | 持股 | | | | | | | | 质押、标记或冻结 | | 股东名称 | | | | | | | | | | | 售条件的 | | | | | | | 质 例(%) | | | | | | | | 数量 | | | | | | | 股份数量 | | | | | | | | | | | | | 股份数量 | | | | | | | | 境内非 | | | | | | | | | | | | | | | | | | 江苏济川控股集团有限公 | | | | | | | | | | | | | | | | | | 国有法 | | | | | 45.22 | | | 416,757,360 | | | | 0 | 质押 | | | 108,200,000 | | 司 | | ...